Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FS19G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,062
Award facts
- Contract value 100% obligated
- $18,061.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,061.85 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order supports the Defense Health Agency's pharmaceutical supply needs through the DLA Medical Supply Chain. RINVOQ (upadacitinib) is a Janus kinase inhibitor used in treating rheumatoid arthritis and other inflammatory conditions, reflecting the breadth of specialty medications AmerisourceBergen supplies to federal military and veteran healthcare systems. The parent IDC vehicle demonstrates AmerisourceBergen's established capability as a critical pharmaceutical vendor, enabling the company to fulfill federal procurement requirements across multiple therapeutic domains for military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FS19G?
SPE2DR26FS19G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FS19G worth?
The government has obligated $18,062 on SPE2DR26FS19G.
Is contract SPE2DR26FS19G an order under another contract?
Yes. SPE2DR26FS19G is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS19G competed?
The extent of competition for SPE2DR26FS19G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award